MWM
REGN icon

Modera Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Modera Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.17M Sell
6,682
-69
-1% -$47K 0.04% 202
2026
Q1 		$5.22M Sell
6,751
-8
-0.1% -$6.13K 0.06% 174
2025
Q4 		$5.22M Sell
6,759
-115
-2% -$78.1K 0.06% 182
2025
Q3 		$3.87M Sell
6,874
-215
-3% -$122K 0.04% 205
2025
Q2 		$3.72M Sell
7,089
-759
-10% -$424K 0.05% 205
2025
Q1 		$4.98M Sell
7,848
-430
-5% -$296K 0.07% 180
2024
Q4 		$5.9M Sell
8,278
-169
-2% -$142K 0.07% 163
2024
Q3 		$8.88M Sell
8,447
-259
-3% -$288K 0.11% 122
2024
Q2 		$9.15M Sell
8,706
-397
-4% -$385K 0.13% 119
2024
Q1 		$8.76M Sell
9,103
-301
-3% -$286K 0.13% 124
2023
Q4 		$8.26M Sell
9,404
-179
-2% -$147K 0.14% 122
2023
Q3 		$7.89M Buy
9,583
+270
+3% +$212K 0.15% 117
2023
Q2 		$6.69M Buy
+9,313
New +$7.18M 0.12% 128

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Modera Wealth Management's REGN Position: Q2 2026 in Review

Modera Wealth Management reduced its Regeneron Pharmaceuticals (REGN) stake by 1% in Q2 2026, selling an estimated $47K and leaving 6,682 shares worth $4.17M. The position accounts for 0.04% of the portfolio, ranked #202.

Modera Wealth Management first reported a position in REGN in Q2 2023 and has held it in 13 quarters since. The position peaked at $9.15M in Q2 2024. 729 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Modera Wealth Management held 6,682 shares of Regeneron Pharmaceuticals worth $4.17M as of Q2 2026.
  • Modera Wealth Management sold 69 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $47K.
  • Regeneron Pharmaceuticals made up 0.04% of Modera Wealth Management's portfolio in Q2 2026, its #202 holding.
  • Modera Wealth Management first reported a position in Regeneron Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • Modera Wealth Management's Regeneron Pharmaceuticals position peaked at $9.15M in Q2 2024.
  • 729 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Modera Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.